AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for BEAM THERAPEUTICS · Biotechnology & drug development

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 16, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Lobbying activity 1

Health Issues

-cell and gene therapy policy

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.